John B. Henneman III, Director at Aprea Therapeutics, Inc. (APRE), bought 13,720 shares at $7.29 ($100K) on 2024-03-13, disclosed to the SEC on 2024-03-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.29 | 6,860 | $50K | 50.0% |
| 2 | $7.29 | 6,860 | $50K | 50.0% |
| Total | $7.29 avg | 13,720 | $100K | 100% |
| Filing → |
| RCM | SELL | 2023-08-09 | $1.7M | — | Filing → |
| ANIK | BUY | 2021-05-20 | $86K | — | Filing → |
| SPNE | SELL | 2020-08-05 | $150K | — | Filing → |